Clinical trial NCT06508411: Exploration of the Relationship Between Sexual Health and Pain in the Context of Cancer in France
Official title: Exploration of the Relationship Between Sexual Health and Pain in the Context of Cancer in France: Cross-sectional Study
Study type: OBSERVATIONAL
Overall status: NOT_YET_RECRUITING
Conditions: Pain
Cancer
Survivorship
Keywords: pain
neuropathic pain
sexual health
cancer patients
cancer survivors
Lead sponsor: University Hospital, Clermont-Ferrand
Sponsor class: OTHER
First posted: 2024-07-18
Enrollment: 1000
Sex: ALL
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Observational model: COHORT
Time perspective: CROSS_SECTIONAL
Sampling method: NON_PROBABILITY_SAMPLE
Study population: Cancer patients and cancer survivors recruited via cancer patient associations

Brief summary: The goal of this observational study is to explore the relationship between pain and sexual health in the context of cancer (cancer patients and cancer survivors). The main question it aims to answer is:

- Does pain interfere with sexual health in cancer patients and cancer survivors?

Detailed description: Participants will be recruited through French cancer patient associations and will be invited to complete an online survey questionnaire, exploring:

* Sexual health and sexual satisfaction
* Pain severity and impact on daily activities
* Neuropathic pain
* Migraine
* Chemotherapy-induced peripheral neuropathy
* Quality of life, functioning, and symptoms
* Anxiety and depression
* Sociodemographic characteristics of patients
* Oncological characteristics

Eligibility criteria: Inclusion Criteria:

- Declaring themselves to be suffering from or having suffered from cancer recruited as such via appropriate communication systems (patient associations and social networks, etc.)

Exclusion Criteria:

* No command of the French language
* Residence outside France (verified with the department of residence in the questionnaire)
* Patient Companion
* Protected adult

Primary outcomes:
measure: presence of pain
timeFrame: day 1
measure: Sexual satisfaction
timeFrame: day 1
Secondary outcomes:
measure: Sexual satisfaction
timeFrame: day 1
measure: Quality of the sexual health
timeFrame: day 1
measure: Pain severity and characteristics
timeFrame: day 1
measure: Presence of neuropathic pain
timeFrame: day 1
measure: Presence of migraine
timeFrame: day 1
measure: Severity of chemotherapy-induced peripheral neuropathy (sensory and motor)
timeFrame: day 1
measure: Assessment of the quality of life
timeFrame: day 1
measure: Assessment of the functioning dimensions
timeFrame: day 1
measure: Assessment of the severity of symptoms
timeFrame: day 1
measure: Sociodemographic characteristics - age of patients
timeFrame: day 1
measure: Sociodemographic characteristics - gender
timeFrame: day 1
measure: Sociodemographic characteristics - body mass index
timeFrame: day 1
measure: Sociodemographic characteristics - use of alcohol, tobacco, e-cigarette, cannabis;
timeFrame: day 1
measure: Sociodemographic characteristics - marital status
timeFrame: day 1
measure: Sociodemographic characteristics - socioprofesional status
timeFrame: day 1
measure: Sociodemographic characteristics - living area
timeFrame: day 1
measure: Oncological characteristics - past and/or ongoing treatment
timeFrame: day 1
measure: Oncological characteristics - type of cancer
timeFrame: day 1
measure: Oncological characteristics - date of cancer diagnosis
timeFrame: day 1
Other outcomes:
Locations:
city: Clermont-Ferrand
country: France
facility: CHU Clermont-Ferrand
Study officials:
affiliation: University Hospital, Clermont-Ferrand
name: David BALAYSSAC
role: PRINCIPAL_INVESTIGATOR
References: